Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Perrigo Company    PRGO

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Wall Street surges to five-year highs; Dow ends above 14,000

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/01/2013 | 10:39pm CEST

Stocks rose to five-year highs on Friday, with the Dow closing above 14,000 for the first time since October 2007, after jobs and manufacturing data showed the economy's recovery remains on track.

The S&P touched its highest since December 2007 after a 5 percent gain in January, which was its best start to a year since 1997. The index is now just about 60 points away from its all-time intraday high of 1,576.09.

Employment grew modestly in January, with 157,000 jobs added. That was slightly below expectations, but Labor Department revisions showed 127,000 more jobs were created in November and December than previously reported.

Analysts attributed the market's robust showing so far this year partly to a deluge of cash flowing into equities.

Investors poured $12.7 billion into U.S.-based stock mutual funds and exchange-traded funds in the latest week, concluding the strongest four-week flows into stock funds since 1996, data showed on Thursday.

"There is a lot of money looking for a home, and people are finally deciding the bond market is done and moving money into equities," said Edward Simmons, managing director and partner at HighTower in Portland, Maine.

"I see the rotation (of assets) pushing the market up in the face of not-massive amounts of good news," he said. "People are overlooking the higher risk in equities."

Other reports released Friday showed the pace of growth in the U.S. manufacturing sector picked up in January to its highest level in nine months, U.S. consumer sentiment rose more than expected last month, while December construction spending also beat forecasts.

"All the data seems to keep pointing to a slowly, steadily improving economy," said Eric Kuby, chief investment officer at North Star Investment Management Corp in Chicago.

The Dow Jones industrial average <.DJI> was up 149.21 points, or 1.08 percent, at 14,009.79. The Standard & Poor's 500 Index <.SPX> was up 15.06 points, or 1.01 percent, at 1,513.17. The Nasdaq Composite Index <.IXIC> was up 36.97 points, or 1.18 percent, at 3,179.10.

With the day's gains, major equity indexes rose five straight weeks.

More than 600 stocks on the NYSE and the Nasdaq combined hit 52-week highs on Friday, including Google <GOOG.O.> which rose as high as $776.60, before closing at $775.60, up 2.6 percent.

Investors were also attuned to corporate earnings, with a trio of Dow components reporting profits that beat expectations.

Exxon Mobil (>> Exxon Mobil Corporation) ended flat at $90.04 after reporting results while Chevron (>> Chevron Corporation) added 1.2 percent to $116.50.

Drugmaker Merck & Co (>> Merck & Co., Inc.) fell 3.3 percent to $41.83 after a cautious 2013 outlook.

Generic drugmaker Perrigo (>> Perrigo Company) reported a better-than-expected second-quarter profit and its shares jumped 4.7 percent to $105.28.

Of the 252 companies in the S&P 500 that have reported earnings so far, 69 percent have exceeded expectations, according to Thomson Reuters data. That is a higher proportion than over the past four quarters and above average since 1994.

Overall, S&P 500 fourth-quarter earnings are estimated to have grown 4.4 percent, according to the data, up from a 1.9 percent forecast at the start of the earnings season but well below a 9.9 percent profit growth forecast on October 1.

Dell Inc (>> Dell Inc.) gained 2.9 percent to $13.63 after sources said the company was nearing an agreement to sell itself to a buyout consortium led by its founder, Michael Dell, and private equity firm Silver Lake Partners.

(Reporting By Angela Moon; Editing by Kenneth Barry)

By Angela Moon

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PERRIGO COMPANY
07/24 PERRIGO CO PLC : Material Modification to Rights of Security Holders, Submission..
07/21 PERRIGO : Change in Directors or Principal Officers, Financial Statements and Ex..
07/20 PERRIGO : Gets FDA Approval for Generic Topical Gel
07/19 PERRIGO : Announces FDA Final Approval For Its AB Rated Generic Version Of DermO..
07/17 PERRIGO : Confirms Patent Challenge For Generic Version Of Soolantra® Cream, 1%
07/17 PERRIGO : Announces FDA Final Approval For Its First-To-File Ab Rated Generic Ve..
07/17 PERRIGO : Announces Settlement Of Generic Version Of Dymista® Nasal Spray Patent..
07/13 PERRIGO : Launches The Generic Version Of Axiron® Topical Solution
07/11 PERRIGO : Global Analgesics Market 2017 - Crown Pharmaceuticals, Perrigo Company..
07/06DJJEFF FETTIG : For CEOs, High Pay, Higher Anxiety -- WSJ
More news
Financials ($)
Sales 2017 4 769 M
EBIT 2017 912 M
Net income 2017 289 M
Debt 2017 2 653 M
Yield 2017 0,88%
P/E ratio 2017 38,04
P/E ratio 2018 23,40
EV / Sales 2017 2,85x
EV / Sales 2018 2,66x
Capitalization 10 938 M
Income Statement Evolution
Consensus
 
Mean consensus HOLD
Number of Analysts 17
Average target price 76,0 $
Spread / Average Target -0,37%
EPS Revisions
Managers
NameTitle
John T. Hendrickson Chief Executive Officer & Director
Mary Lauren Brlas Chairman
Ron L. Winowiecki Chief Financial Officer
Thomas Farrington Chief Information Officer & Executive VP
Grainne Quinn Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
PERRIGO COMPANY10 938
JOHNSON & JOHNSON14.47%355 263
NOVARTIS7.35%220 651
ROCHE HOLDING LTD.4.30%220 599
PFIZER1.91%197 115
MERCK AND COMPANY5.93%170 565